Search For "covid 19 vaccine"
COVID-19 vaccine likely by first quarter of 2021: Harsh Vardhan
Updated : 5 years, 6 months ago IST
New Delhi [India], September 13 (ANI): The COVID-19 vaccine might be ready by the first quarter of 2021, Union Health Minister Dr Harsh Vardhan said on Sunday.
Read More
Suspension of AstraZeneca COVID-19 vaccine trials showed fallacy of approa
Updated : 5 years, 6 months ago IST
Moscow [Russia], September 13 (ANI): Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev on Saturday said that temporary suspension of AstraZeneca COVID-19 vaccine candidate trials clearly showed the "fallacy of the approach" when countries "exclusively rely on novel and untested platf
Read More
Serum Institute to resume COVID-19 vaccine trials in India after DCGI nod
Updated : 5 years, 6 months ago IST
New Delhi [India], September 12 (ANI): Hours after clinical trials for AstraZeneca and Oxford University coronavirus vaccine resumed on Saturday in the UK, pharma major Serum Institute of India (SII) said it will resume the trials in India once Drugs Controller General of India (DCGI) gives
Read More
DCGI directs Serum Institute to suspend any new recruitment in phase 2, 3
Updated : 5 years, 6 months ago IST
New Delhi [India], September 12 (ANI): The Drugs Controller General of India (DCGI) Dr VG Somani on Friday ordered the pharma giant Serum Institute of India (SII) to suspend any new recruitment in phase 2 and 3 clinical trials for COVID-19 vaccine till further orders.
Read More
Equity gauges end flat amid gloomy investor sentiment
Updated : 5 years, 6 months ago IST
Mumbai (Maharashtra) [India], September 11 (ANI): Equity benchmark indices closed at near-flat levels on Friday as investors remained cautious about adverse news flow of Covid-19 vaccine trials, simmering India-China geopolitical tensions and a sharp sell-off in US equities.
Read More
AstraZeneca CEO says COVID-19 vaccine may be ready by end of year despite
Updated : 5 years, 6 months ago IST
London [UK], September 10 (ANI/Sputnik): AstraZeneca CEO Pascal Soriot on Wednesday expressed hopes that a vaccine against the novel coronavirus developed by the pharmaceutical company would be ready by the end of 2020 or early 2021, despite having to pause clinical trials.
Read More
Brazil's Bahia state to study Russian coronavirus vaccine
Updated : 5 years, 6 months ago IST
Brasilia [Brazil], September 10 (ANI/Sputnik): The Brazilian state of Bahia has signed an agreement with Russia for access to data on the Russian COVID-19 vaccine, Sputnik V, and intends to conduct its clinical trials, the Folha de Sao Paulo newspaper reported.
Read More
No certainty US will have COVID-19 vaccine before election day: NIH Chief
Updated : 5 years, 6 months ago IST
Washington [US], September 10 (ANI/Sputnik): US National Institutes of Health Director Francis Collins told Congress on Wednesday that it is impossible to say if the United States will have a COVID-19 vaccine by the November presidential election, although he is cautiously optimistic one wil
Read More
Serum Institute says will adhere to DCGI instructions after show cause ove
Updated : 5 years, 6 months ago IST
New Delhi [India], September 9 (ANI): Hours after the Drugs Controller General of India (DCGI) issued a show-cause notice Serum Institute of India (SII) asking for an explanation as to why the ongoing clinical trial of Covishield vaccine candidate has not been suspended till doubts about
Read More
DCGI sends show cause notice to Serum Institute for not pausing trial of
Updated : 5 years, 6 months ago IST
New Delhi [India], September 9 (ANI): The Drugs Regulator General of India (DCGI) has issued a show-cause notice to pharma giant Serum Institute of India (SII) asking for an explanation as to why the ongoing clinical trial of Covishield vaccine candidate has not been suspended till doubts
Read More
Oxford COVID-19 vaccine trials not paused in India, clarifies Serum Instit
Updated : 5 years, 6 months ago IST
New Delhi [India], September 9 (ANI): After AstraZeneca suspended the trials of COVID-19 vaccine in the UK, Indian pharmaceutical giant Serum Institue of India (SII) on Wednesday clarified that testing of the possible vaccine candidate in India is ongoing and has not faced any issue so far.
Read More
AstraZeneca says COVID-19 vaccine trial paused due to unexplained illness
Updated : 5 years, 6 months ago IST
London [UK], September 9 (ANI): UK-based biopharma giant AstraZeneca has said that the phase 3 testing of its COVID-19 vaccine being developed with Oxford University has been put on hold, due to a suspected serious adverse reaction in a participant in the United Kingdom.
Read More